Published in Medical Letter on the CDC and FDA, September 9th, 2007
"Indeed, treatment with the proteasome inhibitor MG - 132 of skeletal muscles from mdx mice - a spontaneous mouse model of DMD - as well as from DMD patients, effectively rescued the expression and correct cellular localization of dystrophin and associated proteins. These promising...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA